RxDoctor Payments Data

Oghale Eleyae, DPM

Podiatrist · Natchitoches, LANPI 1811148539

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (40.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Stryker at 45.3% of the total. 2025 is the largest year on record at $4,851, 3.9 times the $1,233 reported in 2019. Among podiatrist clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,906in general payments, 2019–2025

Across 96 payments — averaging $124.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$5K
  • Convatec Inc.$5K
  • Organogenesis Inc.$616
  • Kerecis Limited$384
  • Paratek Pharmaceuticals, Inc.$368
  • AbbVie$66
  • plus $164 from 6 others

What the payments were for

  • Travel & lodging$4,39637%
  • Food & beverage$2,71023%
  • Other$4,80040%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,906 in reported general payments places this provider in the 90th percentile of 68 podiatrist providers in Louisiana.

See all podiatrist providers in Louisiana

Medicare billing

Part B allowed, 2024
$307,910
Medicare patients
293
Services billed
1,647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole166$4,181
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip74$2,661
Ammonium Lactate108$2,436
Amitriptyline Hcl230$1,788
Diclofenac Sodium48$1,031
Gabapentin133$1,007
Terbinafine Hcl43$998
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen106$838
Ibuprofen88$815
Lidocaine13$756
Methylprednisolone91$595
Naproxen58$441
Meloxicam140$395
Clindamycin Hcl84$390
Mupirocin31$356

Paid to pharmacies, not to this prescriber.

Other podiatrist in Natchitoches

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →